Deerland will introduce its newest branded product, Solarplast® at this year’s Engredea/Expo West trade show in Anaheim, CA. Solarplast is an extract of organic dark leafy greens, which is enzymatically enhanced by a unique and proprietary manufacturing process. It utilizes the power of the chloroplasts found in dark leafy greens to provide a rich source of molecular chaperones and antioxidants, all in a naturally occurring lipid protective coating.
Researchers have found that consumption of Deerland Probiotics & Enzymes’ probiotic strain DE111® can improve occasional constipation and/or diarrhea in healthy individuals, according to a study recently published in the Journal of Probiotics & Health.
Deerland Probiotics & Enzymes is pleased to announce that it has earned Non-GMO Project verification for Dairylytic® and Glutalytic®, the company’s branded enzyme blends for dairy and gluten digestion.
Deerland Probiotics & Enzymes is pleased to announce that it has received a notice of allowance for its US patent application directed to prebiotic compositions comprising bacteriophages, namely Deerland’s branded prebiotic, PreforPro.
Deerland Probiotics & Enzymes is pleased to announce that it has earned Non-GMO Project verification for ProHydrolase, the company’s branded enzyme blend for protein digestion.
The gut microbiome is one of the most exciting areas of scientific study today. There’s no better way to learn about it than at SupplySide West, held from September 27 to 28, in Las Vegas, Nevada. This premier tradeshow assembles more than 15,000 ingredient buyers and suppliers from the dietary supplement, beverage, functional food, personal care, and sports nutrition industries. SupplySide West provides industry leaders a closer look at the science and strategy around the development of finished products, with over 1,200 exhibitors and 140 hours of educational and conference programming.
Deerland Probiotics & Enzymes is pleased to announce that it has earned the ISO/IEC 17025:2005 certification from the ANSI-ASQ National Accreditation Board (ANAB).
RoundTable Healthcare Partners (“RoundTable”), an operating-oriented private equity firm focused exclusively on the healthcare industry, announced today that it has made an investment in Deerland Probiotics & Enzymes (“Deerland” or the “Company”). Financial terms of the transaction were not disclosed.
DE111® Probiotic Provides Benefits for Body Fat Percentage and Athletic Performance, According to Latest Study
Researchers have found that consumption of the probiotic strain DE111® in conjunction with adequate post-workout nutrition can improve body composition and indices of athletic performance during offseason training in collegiate athletes.
The study found that compared to the placebo, the probiotic DE111 produced statistically significantly improvements in the reduction of body fat percentage, and a strong trend indicating improved performance of the deadlift exercise. “These findings are encouraging for athletic individuals, both professional and recreational, that are looking for ways to naturally achieve maximum results from their training efforts,” said Dr. John Deaton, vice president of science and technology at Deerland Probiotics & Enzymes.
Deerland Probiotics & Enzymes has been granted a Natural Product Number (NPN) for Bacillus subtilis DE111, a genome sequenced and clinically studied probiotic strain that supports gut health. This new product license issuance by the Natural Health Products Directorate of Health Canada (NPN 80077102) allows DE111 to be sold throughout Canada.